openPR Logo
Press release

Top Factor Driving Faecal Extraction Systems Market Growth in 2025: The Impact Of Rising Inflammatory Bowel Disease Prevalence On The Faecal Extraction Systems Market

02-26-2025 08:45 AM CET | Health & Medicine

Press release from: The Business Research Company

Faecal Extraction Systems Market Size

Faecal Extraction Systems Market Size

What combination of drivers is leading to accelerated growth in the faecal extraction systems market?
The escalating occurrence of inflammatory bowel disease (IBD) is anticipated to fuel the faecal extraction systems market growth in the future. IBD comprises a group of diseases typified by chronic inflammation in the digestive system tissues. Faecal extraction systems find a variety of uses in the diagnosis, regulation of disease activity, treatment planning, prediction of disease recurrence and post-operative repetition in IBD. Consequently, the rising occurrence of IBD enhances the requirement for faecal extraction systems. For example, the Impact of IBD Report 2023 released by the IBD Clinical and Research Centre, a Canadian institution focused on bettering the lives of patients with Crohn's disease and ulcerative colitis, indicated that there were over 320,000 Canadians with IBD in September 2023, a prevalence of 825 per 100,000. The same report anticipates that IBD prevalence will increase 2.44% annually, reaching 1.1% of the population, or 470,000 Canadians, by 2035. Hence, the growing occurrence of IBD is predicted to boost the faecal extraction systems market.

Get Your Faecal Extraction Systems Market Report Here:
https://www.thebusinessresearchcompany.com/report/faecal-extraction-systems-global-market-report

What is the projected compound annual growth rate (CAGR) of the faecal extraction systems market from 2025 to 2034, and what factors influence it?
In recent times, there has been a consistent expansion in the size of the faecal extraction systems market. This market will rise from $1.66 billion in 2024 to $1.71 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 3.3%. The historic growth in this market can be linked to factors such as ethical considerations and strict guidelines, economic scenarios, disruption in research work, impact of the COVID-19 pandemic, and a higher incidence of inflammatory bowel disease (IBD).

The market size for faecal extraction systems is set to witness robust expansion in the coming years, with predictions suggesting it will surge to $2.14 billion by 2029, reflecting a compound annual growth rate (CAGR) of 5.7%. The projected growth during the forecast period can be attributed to factors such as sustainable recovery, regional dominance, government assistance, and investment in research, accelerated by post-covid recovery. Significant trends expected during this period encompass product innovations, strategic marketing and distribution channels, active market participants, economic landscape and technological advancements.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8297&type=smp

How are the latest trends influencing the growth of the faecal extraction systems market?
Several leading firms in the faecal extraction system industry are pioneering innovative solutions such as fecal DNA tests in an effort to reach a wider customer network, boost sales, and ultimately, increase their revenue stream. Fecal DNA tests offer a non-invasive diagnostic method by examining DNA found in an individual's faecal sample. A notable example occurred in March 2023, when BGI Genomics, a biotech company headquartered in China, alongside Zentya, a renowned Slovakia-based genetics screening service, unveiled COLOTECT 1.0. This ground-breaking fecal DNA test is highly regarded for its non-invasive approach and its capacity to identify colorectal cancer and pre-cancerous conditions in Slovakia. COLOTECT 1.0 makes use of multiplex methylation-specific PCR technology, thus facilitating the detection of irregular colorectal cancer DNA-methylation biomarkers within fecal samples.

What are the major segments of the faecal extraction systems market and their role in driving growth?
The faecal extraction systems market covered in this report is segmented -

1) By Assay: Calprotectin, Albumin, Hemoglobin, Bile Acids
2) By Analysis Test: Microscopic, Chemical, Immunological, Microbiological
3) By Indication: Parasitic Infection, Viral Infection, Bacterial Indication, Poor Nutrient Absorption
4) By End-Use: Diagnostic Centers, Hospitals And Clinics, Ambulatory Clinics, Research Centers

Subsegments:
1) By Calprotectin: Quantitative Calprotectin Assays, Qualitative Calprotectin Assays
2) By Albumin: Fecal Albumin Assays, Albumin-To-Creatinine Ratio Assays
3) By Hemoglobin: Fecal Occult Blood Tests (FOBT), Immunochemical Fecal Hemoglobin Tests
4) By Bile Acids: Fecal Bile Acid Assays, Bile Acid Malabsorption Tests

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8297

Which regions are key players in the growth of the faecal extraction systems market?
North America was the largest region in the faecal extraction systems market in 2024. The regions covered in the faecal extraction systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the faecal extraction systems market?
Major companies operating in the faecal extraction systems market are Alpha Laboratories Ltd., Arbor Assays, bioMérieux SA, Buhlmann Laboratories AG, Calpro AS, DRG Instruments GmbH, Promega Corporation, Werfen SA, Mobidiag Oy, Biohit Healthcare Ltd., Meridian Bioscience Inc., Quidel Corporation, DiaSorin SpA, Sekisui Diagnostics LLC, Hologic Inc., Abbott Laboratories, Roche Diagnostics Corporation, Siemens Healthineers, Beckman Coulter Inc., Cepheid Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Luminex Corporation, QIAGEN NV, Quest Diagnostics Incorporated, Randox Laboratories Ltd., Thermo Fisher Scientific Inc., Trinity Biotech plc

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8297&type=smp

What Is Covered In The Faecal Extraction Systems Global Market Report?

• Market Size Forecast: Examine the faecal extraction systems market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the faecal extraction systems market for a structured understanding.
• Key Players Overview: Analyze major players in the faecal extraction systems market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the faecal extraction systems market.
• Segment Contributions: Evaluate how different segments drive overall growth in the faecal extraction systems market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the faecal extraction systems market.
• Industry Challenges: Identify potential risks and obstacles affecting the faecal extraction systems market.
• Competitive Landscape: Review strategic developments in the faecal extraction systems market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Top Factor Driving Faecal Extraction Systems Market Growth in 2025: The Impact Of Rising Inflammatory Bowel Disease Prevalence On The Faecal Extraction Systems Market here

News-ID: 3887554 • Views:

More Releases from The Business Research Company

Global Dermal Regeneration Market Expansion at 8.9% CAGR, Valued at $2.52 Billion by 2029
Global Dermal Regeneration Market Expansion at 8.9% CAGR, Valued at $2.52 Billio …
"Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. What Are the Dermal Regeneration Market Size Forecast for 2025? In recent years, the market size of dermal regeneration has significantly expanded. Its growth is set to continue, moving from a market value of $1.64 billion in 2024, surging to $1.79 billion in 2025, indicating a Compound Annual Growth Rate
Dental Emergency Kit Market Expansion Outlook: $1.74 Billion in 2029
Dental Emergency Kit Market Expansion Outlook: $1.74 Billion in 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. What Is the Projected CAGR for the Dental Emergency Kit Market from 2024 to 2025? In recent times, the dental emergency kit market has seen significant growth. Projected growth rates suggest an increase from $1.18 billion in 2024 to $1.28 billion in 2025, manifesting a compound annual growth rate (CAGR) of 8.2%.
Cryopreservation Equipment Industry Growth Outlook: 15.4% CAGR and $19.55 Billion by 2029
Cryopreservation Equipment Industry Growth Outlook: 15.4% CAGR and $19.55 Billio …
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. What Is the Long-Term Growth Forecast for the Cryopreservation Equipment Market Size 2025? The expansion of the cryopreservation equipment market has been significant in recent years. The market which is expected to escalate from $9.52 billion in 2024 to $11.01 billion in 2025, will do so with a compound annual growth rate
Connected Wearable Patches Industry to Achieve $10.78 Billion Growth by 2029
Connected Wearable Patches Industry to Achieve $10.78 Billion Growth by 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. How Will the Connected Wearable Patches Market Grow by 2025 in Terms of Size and Growth? The market size for connected wearable patches has seen significant expansion in the most recent years. With an expected rise from $5.62 billion in 2024 to $6.42 billion in 2025, representing a compound annual growth rate

All 5 Releases


More Releases for IBD

Ace Therapeutics Unveils Imaging Services for Precise Characterization of IBD An …
Ace Therapeutics launched its translational imaging services specifically designed to accurately characterize Inflammatory Bowel Disease (IBD) animal models. New York, USA - May 28, 2025 - Ace Therapeutics, a leader in preclinical research solutions, launched its translational imaging solutions specifically designed to accurately characterize Inflammatory Bowel Disease (IBD) animal models. This breakthrough offering empowers researchers with high-resolution, quantitative data to enhance drug development and mechanistic studies. Image: https://www.getnews.info/uploads/3c0755ac659fa5075e809ffd1b893496.jpg Imaging techniques play a crucial
Inflammatory Bowel Disease (IBD) Market Size, Growth Insights, and Future Trends
Inflammatory Bowel Disease (IBD) continues to pose significant challenges for individuals and healthcare systems worldwide. With its increasing prevalence, the demand for effective treatments is driving market growth. The IBD treatment market is projected to grow from USD 19.91 billion in 2023 to USD 33.19 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.5% during the forecast period. Download Statistical Data: https://www.towardshealthcare.com/download-statistics/5149 Key Market Highlights • Crohn's Disease Dominates: Crohn's disease
Canada Inflammatory Bowel Disease (IBD) Market Size & Growth Analysis Report, 20 …
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn’s disease,
Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031
Visiongain has published a new report on Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031: Forecasts by Drug Class (Biologics, Aminosalicylates, Corticosteroids, Antibiotics, Immunomodulators, Others), by Indication (Crohn’s Disease, Ulcerative Colitis), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading IBD Drug Companies AND COVID-19 Recovery Scenarios. Global Inflammatory Bowel Disease (IBD) drugs market was valued at US$ US$xx
US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 20 …
The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. The factors such as the significant prevalence of IBD such as Crohn’s disease and ulcerative colitis across the country contributing to the market growth. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohn’s disease and ulcerative colitis in the US was 201 and 238 per
Global Inflammatory Bowel Disease (IBD) Therapeutics Market, Share, Trends & For …
The global IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.0% during the forecast period. The rise in the number of IBD such as Crohn's disease and ulcerative colitis is augmenting the growth of the global IBD therapeutics market. The increasing prevalence of IBD results in the need for research for the treatment of IBD and innovations in healthcare systems to manage this complex and